Abbvie Inc

NYSE:ABBV   3:59:58 PM EDT
+1.00 (+0.92%)
4:00:00 PM EDT: $109.46 -0.04 (-0.04%)

Alvotech Says FDA Defers Action on Application For Proposed Humira Biosimilar

Published: 09/20/2021 14:34 GMT
Abbvie Inc (ABBV) - Alvotech Provides Update on FDA Action Regarding Avt02, Proposed High-concentration Biosimilar to Humira® (adalimumab).
Alvotech: FDA Deferring Action on Application for Avt02, Proposed Biosimilar to Humira, Until Facility Assessments Can Be Completed.
Alvotech: Continues to Work With FDA to Coordinate Required Inspection(s) in Safe and Adequate Manner.